[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100563288":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":22,"locations":28,"responsibleParty":40,"collaborators":10,"id":42,"slug":43,"hasResults":44,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":10,"eligibilityCriteria":48,"healthyVolunteers":44,"sex":49,"minAge":50,"maxAge":51,"enrollmentInfo":52,"targetDuration":10,"studyType":55,"phases":10,"briefSummary":56,"conditions":57,"keywords":59,"overallStatus":67,"whyStopped":10,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"Sanoculis Ltd","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"MIMS Surgery Cohort",null,"This cohort consists subjects treated with MIMS® Device as a standalone procedure during time period (27 Sep 2023 - 31 May 2025), and with documented post-operative follow-up available in the medical charts.",[13],"Device: Minimally Invasive Micro Sclerostomy",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Minimally Invasive Micro Sclerostomy","The MIMS® procedure uses the proprietary MIMS® device, which creates a sclerostomy in the eye.",[9],[21],"MIMS",[23],{"name":24,"role":25,"phone":26,"phoneExt":10,"email":27},"Khan Lau, OD","CONTACT","8082862666","khan@sanoculis.com",[29],{"facility":30,"status":10,"city":31,"state":10,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":10},"S. Malayan Eye Center","Yerevan","Armenia","AM",{"type":35,"coordinates":36},"Point",[37,38],44.5126,40.17765,{"lat":38,"lon":37},{"type":41,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100563288","mims-retrospective-chart-review-100563288",false,"NCT06614218","MIMS® Retrospective Chart Review","Minimally Invasive Micro Sclerostomy (MIMS®) Retrospective Chart Review","Inclusion Criteria:\n\n1. Eye treated with MIMS® Device as a standalone procedure\n2. MIMS® surgery was performed between 27 Sep 2023 and 30 April 2024","ALL","40 Years","85 Years",{"count":53,"type":54},40,"ESTIMATED","OBSERVATIONAL","This is a post-market clinical follow-up, retrospective chart review of MIMS® surgical procedures conducted during time period between Sep 2023 and May 2025.",[58],"Open Angle Glaucoma",[60,61,21,62,63,64,65,66],"Polypharmacy","Intraocular Pressure","Minimally Invasive Glaucoma Surgery","MIGS","MTMT","Trabeculectomy","Sclerostomy","NOT_YET_RECRUITING","2025-01-08",{"date":70,"type":71},"2025-01-10","ACTUAL",{"date":73,"type":54},"2025-02-01",{"date":75,"type":54},"2026-01-01",{"name":5,"class":6},1]